AIC
KRYS icon

Archer Investment Corporation’s Krystal Biotech KRYS Stock Holding History

Archer Investment Corporation’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Buy
830
+100
+14% +$29.9K 0.06% 244
2026
Q1 		$189K Buy
+730
New +$194K 0.04% 320

Other funds holding KRYS

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Archer Investment Corporation's KRYS Position: Q2 2026 in Review

Archer Investment Corporation increased its Krystal Biotech (KRYS) stake by 14% in Q2 2026, buying an estimated $29.9K and bringing the position to 830 shares worth $308K. The position accounts for 0.06% of the portfolio, ranked #244.

Archer Investment Corporation first reported a position in KRYS in Q1 2026 and has held it in 2 quarters since. 129 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Archer Investment Corporation held 830 shares of Krystal Biotech worth $308K as of Q2 2026.
  • Archer Investment Corporation bought 100 Krystal Biotech shares in Q2 2026, an estimated $29.9K.
  • Krystal Biotech made up 0.06% of Archer Investment Corporation's portfolio in Q2 2026, its #244 holding.
  • Archer Investment Corporation first reported a position in Krystal Biotech in Q1 2026 and has held it in 2 quarters since.
  • 129 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.